✦ LIBER ✦

Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism

✍ Scribed by Jan Gerard Maring; Floris M. Wachters; Monique Slijfer; J. Marina Maurer; H. Marike Boezen; Donald R. A. Uges; Elisabeth G. E. de Vries; Harry J. M. Groen

Publisher: Springer
Year: 2010
Tongue: English
Weight: 152 KB
Volume: 66
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-010-0799-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Letter to the editor: pharmacokinetics o

Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism

✍ Cédric Mercier; Laetitia Dahan; L’Houcine Ouafik; Nicolas André; Joseph Ciccolin 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 63 KB

Pharmacology of the paclitaxel–cisplatin

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Activity of gemcitabine in non-small-cel

Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study

✍ Minoru Takada; Shun-ichi Negoro; Shinzo Kudo; Kiyoyuki Furuse; Hideki Nishikawa; 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 177 KB

Phase II study of gemcitabine and carbop

Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer

✍ Lin Run Wang; Ming Zhu Huang; Guo Bing Zhang; Nong Xu; Xiu Hua Wu 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 385 KB

The pooled analysis of single gemcitabin

The pooled analysis of single gemcitabine for non-small cell lung cancer patients with elderly age

✍ Fang Wang; Liangping Xia; Guifang Guo; Huijuan Qiu; Feifei Zhou; Wenzhuo He 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 289 KB

Impact of functionalABCG2polymorphisms o

Impact of functionalABCG2polymorphisms on the adverse effects of gefitinib in Japanese patients with non–small-cell lung cancer

✍ Keiichi Akasaka; Takayuki Kaburagi; Shin’ichi Yasuda; Kyoko Ohmori; Kaori Abe; H 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 212 KB